NEW YORK (GenomeWeb News) – Qiagen's acquisition last week of additional PCR licenses from Roche and Idaho Technology will bolster the company's PCR business on several fronts, including hardware, consumables, and in vitro diagnostics, according to a company official.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.